Inhibition of Prostate Cancer via Inhibition of Peptidylglycine α-Amidating Monooxygenase (PAM)

Inhibition of Prostate Cancer via Inhibition of Peptidylglycine α-Amidating Monooxygenase (PAM)

Bibliographic Details
Main Author:	Bearss, Nicole R.
Language:	English
Published:	University of Toledo / OhioLINK 2011
Subjects:	Biology Pharmaceuticals Pharmacology PAM hormone refractory prostate cancer peptidylglycine alpha-amidating monooxygenase DU145 prostate cancer
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=toledo1302200866

Similar Items

The peptidylglycine-α-amidating monooxygenase (PAM) gene rs13175330 A>G polymorphism is associated with hypertension in a Korean population
by: Hye Jin Yoo, et al.
Published: (2017-11-01)

A bioactive peptide amidating enzyme is required for ciliogenesis
by: Dhivya Kumar, et al.
Published: (2017-05-01)

New Peptide-pair Screening Strategy and Peptidylglycine a-Hydroxylating Monooxygenase (PHM) Based Enrichment Method for the Discovery of Novel a-Amidated Peptides
by: An, Zhenming
Published: (2010)

Mechanistic Studies of Peptidylglycine Alpha-Amidating Monooxygenase (PAM)
by: McIntyre, Neil R
Published: (2008)

Peptidylglycine monooxygenase activity of monomeric species of growth hormone
by: John Donlon, et al.
Published: (2019-09-01)

Biosynthesis of fatty acid amides
by: Farrell, Emma K
Published: (2010)

Substrate-Based Inhibitors of Peptidylglycine á-Amidating Monooxygenase (PAM) as Anti-Proliferative Drugs for Cancer
by: Chew, Geoffrey H
Published: (2003)

Anticancer activity of midostaurin in hormone refractory human prostate cancer DU145 cells
by: Jin-Jun Sun, et al.
Published: (2016-03-01)

Proteases Shape the Chlamydomonas Secretome: Comparison to Classical Neuropeptide Processing Machinery
by: Raj Luxmi, et al.
Published: (2018-09-01)

Update in palliative management of hormone refractory cancer of prostate
by: Pratipal Singh, et al.
Published: (2007-01-01)

Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer
by: Pascoe Abigail C, et al.
Published: (2012-03-01)

Steady State and Theoretical Investigations of Peptidylglycine α-Amidating Monooxygenase (PAM)
by: Lowe, Edward W
Published: (2008)

Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis
by: Xin Zhang, et al.
Published: (2015-09-01)

Suppression of ANT2 by miR-137 Inhibits Prostate Tumorigenesis
by: Heyuan Zhang, et al.
Published: (2021-09-01)

The Role of Intermittent Chemotherapy in the Survival of Patients with Hormone Refractory Prostate Cancer
by: Mozaffar Aznab, et al.
Published: (2011-09-01)

The Role of Intermittent Chemotherapy in the Survival of Patients with Hormone Refractory Prostate Cancer
by: Jamal Hoseini, et al.
Published: (2011-10-01)

Comparison of Diffusion Kurtosis Imaging and Amide Proton Transfer Imaging in the Diagnosis and Risk Assessment of Prostate Cancer
by: Huijia Yin, et al.
Published: (2021-04-01)

Pathogenesis of prostate cancer and hormone refractory prostate cancer
by: J S Girling, et al.
Published: (2007-01-01)

Effects of Apelin-13 on Human Prostate Cancer Lines [Insan Prostat Kanseri Hucre Serilerinde Apelin-13un Etkileri]
by: Suat Tekin, et al.
Published: (2014-09-01)

Istaroxime Inhibits Motility and Down-Regulates Orai1 Expression, SOCE and FAK Phosphorylation in Prostate Cancer Cells
by: Matias Julian Stagno, et al.
Published: (2017-07-01)

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
by: Geehyun Song, et al.
Published: (2013-09-01)

New therapeutic targets in the treatment of prostate cancer
by: Vivek Vijjan, et al.
Published: (2007-01-01)

MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer
by: Juanni liu, et al.
Published: (2021-01-01)

The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer
by: Li Q, et al.
Published: (2019-12-01)

RUSSIAN EXPERIENCE WITH TAXOTERE USED IN THERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: RESULTS OF THE DESCRIPTIVE TANDEM STUDYA
by: O. B. Karyakin, et al.
Published: (2014-08-01)

RUSSIAN EXPERIENCE WITH TAXOTERE USED IN THERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: RESULTS OF THE DESCRIPTIVE TANDEM STUDYA
by: O. B. Karyakin, et al.
Published: (2014-08-01)

The Effect of Multiplicity of Metastatic Sites on Hormone Refractory Prostate Cancer
by: Amal Halim
Published: (2012-10-01)

Inhibition of Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (YWHAZ) Overcomes Drug Resistance and Tumorigenicity in Ovarian Cancer
by: Lan Hong, et al.
Published: (2018-08-01)

Treatment of Prostate Cancer Cells (DU145) with Gamma-Ray Radiation and Silver Nano Particles
by: A.R. Shams, et al.
Published: (2016-11-01)

Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145
by: Raik Schneider, et al.
Published: (2021-07-01)

Functional Expression of Human Peptidylglycine alpha-Amidating Monooxygenase
by: Hou Ren Wang, et al.
Published: (2003)

EXPERIENCE WITH OCTREOTIDE IN PATIENTS WITH CASTRATION REFRACTORY PROSTATE CANCER
by: D. I. Ganov, et al.
Published: (2014-07-01)

EXPERIENCE WITH OCTREOTIDE IN PATIENTS WITH CASTRATION REFRACTORY PROSTATE CANCER
by: D. I. Ganov, et al.
Published: (2014-07-01)

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
by: Ying Z. Mazzu, et al.
Published: (2020-08-01)

A ROLE OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-07-01)

A ROLE OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-07-01)

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
by: Kai Wang, et al.
Published: (2014-04-01)

Health Services Utilization and Associated Predictors Among Prostate Cancer Patients With and Without Depression in the United States From 2010 to 2015: A Propensity Score-Matched Cross-Sectional Study
by: Alsultan, Mohammed
Published: (2019)

CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
by: Ya. V. Gridneva, et al.
Published: (2014-08-01)

CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
by: Ya. V. Gridneva, et al.
Published: (2014-08-01)